Portfolio Choice in Retirement - What is the Optimal Home Equity Release Product?

2013 ◽  
Author(s):  
Katja Hanewald ◽  
Thomas Post ◽  
Michael Sherris
Keyword(s):  
Portfolio Choice ◽  
Home Equity ◽  
Release Product

Portfolio Choice in Retirement-What is The Optimal Home Equity Release Product?

2015 ◽  
Vol 83 (2) ◽  
pp. 421-446 ◽  
Author(s):  
Katja Hanewald ◽  
Thomas Post ◽  
Michael Sherris
Keyword(s):  
Portfolio Choice ◽  
Home Equity ◽  
Release Product

Portfolio Choice in Retirement: What is the Optimal Home Equity Release Product?

2014 ◽  
Author(s):  
Katja Hanewald ◽  
Thomas Post ◽  
Michael Sherris
Keyword(s):  
Portfolio Choice ◽  
Home Equity ◽  
Release Product

Portfolio Choice in Retirement What is the Optimal Home Equity Release Product?

2014 ◽  
Author(s):  
Katja Hanewald ◽  
Thomas Post ◽  
Michael Sherris
Keyword(s):  
Portfolio Choice ◽  
Home Equity ◽  
Release Product

Home equity and household portfolio choice: Evidence from China

2019 ◽  
Vol 60 ◽  
pp. 149-164 ◽  
Author(s):  
Zekai He ◽  
Xiuzhen Shi ◽  
Xiaomeng Lu ◽  
Feng Li
Keyword(s):  
Portfolio Choice ◽  
Home Equity ◽  
Household Portfolio ◽  
Household Portfolio Choice

The Effect of Home Equity on the Risky Financial Portfolio Choice of Chinese Households

2018 ◽  
Vol 56 (3) ◽  
pp. 543-561 ◽  
Author(s):  
Xiuzhen Shi ◽  
Zekai He ◽  
Xiaomeng Lu
Keyword(s):  
Portfolio Choice ◽  
Home Equity ◽  
Financial Portfolio

Distance bias of socially responsible investment

2018 ◽  
Vol 14 (1) ◽  
pp. 96-110 ◽  
Author(s):  
En Te Chen ◽  
Yunieta Anny Nainggolan
Keyword(s):  
Portfolio Choice ◽  
Distance Effect ◽  
Future Research ◽  
Home Equity ◽  
Socially Responsible ◽  
Content Type ◽  
Responsible Investment ◽  
Local Bias ◽  
Socially Responsible Investments ◽  
Fund Portfolio

Purpose Despite the benefits of international diversification, the home equity bias phenomenon is well documented in the portfolio choice literature. The purpose of this paper is to investigate whether the same investment behavior applies to domestic socially responsible investments (SRIs) where ethical screenings should be the selection criteria. Design/methodology/approach The authors apply the model by Coval and Moskowitz (1999), Grinblatt and Keloharju (2001) and Agarwal and Hauswald (2010) to uncover the effect of distance relative to screenings on SRI domestic portfolio choice. For the first time, the authors test the robustness of distance effect by using time bias, which is the travel time between the fund manager and the company’s headquarter. Findings The authors find that SRIs exhibit a strong preference for locally headquartered firms. After controlling for screening activity and other fund characteristics, the authors still find a strong distance bias in SRI fund portfolio decision-making. The authors find that this bias is mostly observed in SRI fund with social screening and that fund holding characteristics determine the propensity of fund managers to invest locally. The results suggest that the local bias puzzle exists in SRI. Research limitations/implications This study provides avenue for future research to examine whether the same local bias is found in SRI investment in other countries where they have different characteristics and behavior. Also, the evidence that local bias exists in SRI investment may need further analysis as to whether this is conflicting with the objectives of SRI, which focus more on ethical beliefs. Practical implications The results suggest that many local firms in the same city currently held by an SRI fund will not be held by this fund if it is in another city. The implications of the findings are that geographic proximity, along with ethical screenings, is an important dimension to how SRI fund invests. Originality/value This study is the first that examines local bias in SRI funds by using portfolio holding data.

Does Increased Platelet Release Normalize During Anti-Hypertensive Treatment?

1987 ◽  
Vol 58 (03) ◽  
pp. 834-838
Author(s):  
Knut Lande ◽  
Sverre Erik Kjeldsen ◽  
Ivar Eide ◽  
Paul Leren ◽  
Knut Gjesdal
Keyword(s):  
Platelet Function ◽  
Adrenergic Receptor ◽  
Blood Platelet ◽  
Placebo Treatment ◽  
Sampling Procedure ◽  
Β Blocker ◽  
Platelet Release ◽  
Hypertensive Drug ◽  
Second Period ◽  
Release Product

SummaryBlood platelet function was evaluated in 10 men, all 50 years old, with untreated, mild hypertension. Each patient was examined four times: At the beginning of the study, after 5 weeks on placebo treatment, after the following 5 weeks on propranolol 160 mg daily, and finally after a second period of 5 weeks on placebo. At baseline the plasma level of the platelet release product (β-thromboglobulin (BTG) was 41.6 (30.5-57.0) μg/l (median and 95% confidence interval). During the first placebo period BTG was normalized to 21.0 (14.1-25.9) μg/l. While systolic blood pressure and heart rate fell during β-adrenergic receptor blockade, BTG remained unchanged throughout the rest of the observation periods. Platelet size increased significantly during treatment with β-blocker. The present study indicates that the normalization of elevated platelet function which previously has been reported to occur during anti-hypertensive drug therapy, may be explained by patient adaptation to the blood sampling procedure.

Adequate Decision Rules for Portfolio Choice Problems

2002 ◽  
Author(s):  
Thilo Goodall
Keyword(s):  
Portfolio Choice ◽  
Decision Rules
Sign in / Sign up

Export Citation Format

Share Document